Baker Bros. Investments, L.P., Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 144,039 shares at $73.72 ($10.7M) on 2019-03-07, disclosed to the SEC on 2019-03-11.
Open-market sale of $10.7M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.72 | 2 | $147 | 0.0% |
| 2 | $73.72 | 25 | $2K | 0.0% |
| 3 | $73.72 | 29 | $2K | 0.0% |
| 4 | $73.72 | 44 | $3K | 0.0% |
| 5 | $73.72 | 253 | $19K | 0.2% |
| 6 | $73.72 | 1,647 |
| $121K |
| 1.1% |
| 7 | $73.72 | 1,647 | $121K | 1.1% |
| 8 | $73.55 | 22 | $2K | 0.0% |
| 9 | $73.55 | 287 | $21K | 0.2% |
| 10 | $73.55 | 321 | $24K | 0.2% |
| 11 | $73.55 | 495 | $36K | 0.3% |
| 12 | $73.55 | 2,872 | $211K | 2.0% |
| 13 | $73.55 | 2,872 | $211K | 2.0% |
| 14 | $73.55 | 18,703 | $1.4M | 12.8% |
| 15 | $73.55 | 18,703 | $1.4M | 12.8% |
| 16 | $74.03 | 4 | $296 | 0.0% |
| 17 | $74.03 | 51 | $4K | 0.0% |
| 18 | $74.03 | 56 | $4K | 0.0% |
| 19 | $74.03 | 87 | $6K | 0.1% |
| 20 | $74.03 | 506 | $37K | 0.3% |
| 21 | $74.03 | 3,296 | $244K | 2.3% |
| 22 | $74.03 | 3,296 | $244K | 2.3% |
| 23 | $75.08 | 637 | $48K | 0.4% |
| 24 | $75.08 | 982 | $74K | 0.7% |
| 25 | $75.08 | 982 | $74K | 0.7% |
| 26 | $75.08 | 43 | $3K | 0.0% |
| 27 | $75.08 | 37,107 | $2.8M | 26.0% |
| 28 | $75.08 | 37,107 | $2.8M | 26.0% |
| 29 | $75.08 | 5,697 | $428K | 4.0% |
| 30 | $75.08 | 5,697 | $428K | 4.0% |
| 31 | $75.08 | 569 | $43K | 0.4% |
| Total | $74.52 avg | 144,039 | $10.7M | 100% |
| Filing → |